The early predictive value of a decrease of metabolic tumor volume in repeated 18 F-FDG PET/CT for recurrence of locally advanced non-small cell lung cancer with concurrent radiochemotherapy-Reference-Cited by-同舟云学术

The early predictive value of a decrease of metabolic tumor volume in repeated 18 F-FDG PET/CT for recurrence of locally advanced non-small cell lung cancer with concurrent radiochemotherapy

Published:2015-03 Issue:3 Volume:84 Page:482-488
ISSN:0720-048X
Container-title:European Journal of Radiology
language:en
Short-container-title:European Journal of Radiology

Author:

Huang Wei,Liu Bo,Fan Min,Zhou Tao,Fu Zheng,Zhang Zicheng,Li Hongsheng,Li Baosheng

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference29 articles.

1. Recent advances in non-small cell lung cancer biology and clinical management;Saintigny;Discov Med,2012

2. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410;Curran;J Natl Cancer Inst,2011

3. Early prediction of response to first-line therapy using integrated 18F FDG PET/CT for patients with advanced/metastatic non-small cell lung cancer;Lee;J Thorac Oncol,2009

4. Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT;Nahmias;J Nucl Med,2007

5. Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use;Weber;J Clin Oncol,2003

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of node-to-primary tumor maximum standardized uptake value ratio in T1-4N1-3M0 non-small cell lung cancer patients treated with concurrent chemo-radiotherapy;Nuclear Medicine Communications;2022-05-13

2. Geometric and Dosimetric Changes in Tumor and Lung Tissue During Radiotherapy for Lung Cancer With Atelectasis;Frontiers in Oncology;2021-07-22

3. A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients With Non-Small Cell Lung Cancer;Frontiers in Oncology;2020-09-02

4. Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer;Theranostics;2020

5. Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients;Nuclear Medicine Communications;2019-10